Onken MD - Search Results

1

Targeting primary and metastatic uveal melanoma with a G protein inhibitor.

Onken MD, Makepeace CM, Kaltenbronn KM, Choi J, Hernandez-Aya L, Weilbaecher KN, Piggott KD, Rao PK, Yuede CM, Dixon AJ, Osei-Owusu P, Cooper JA, Blumer KJ. Onken MD, et al. J Biol Chem. 2021 Jan-Jun;296:100403. doi: 10.1016/j.jbc.2021.100403. Epub 2021 Feb 10. J Biol Chem. 2021. PMID: 33577798 Free PMC article.

2

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.

Onken MD, Worley LA, Ehlers JP, Harbour JW. Onken MD, et al. Cancer Res. 2004 Oct 15;64(20):7205-9. doi: 10.1158/0008-5472.CAN-04-1750. Cancer Res. 2004. PMID: 15492234 Free PMC article.

3

Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, Harbour JW. Onken MD, et al. Cancer Res. 2006 May 1;66(9):4602-9. doi: 10.1158/0008-5472.CAN-05-4196. Cancer Res. 2006. PMID: 16651410 Free PMC article.

4

Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.

Worley LA, Long MD, Onken MD, Harbour JW. Worley LA, et al. Among authors: onken md. Melanoma Res. 2008 Jun;18(3):184-90. doi: 10.1097/CMR.0b013e3282feeac6. Melanoma Res. 2008. PMID: 18477892

5

Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.

Chang SH, Worley LA, Onken MD, Harbour JW. Chang SH, et al. Among authors: onken md. Melanoma Res. 2008 Jun;18(3):191-200. doi: 10.1097/CMR.0b013e3283005270. Melanoma Res. 2008. PMID: 18477893

6

Oncogenic mutations in GNAQ occur early in uveal melanoma.

Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW. Onken MD, et al. Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5230-4. doi: 10.1167/iovs.08-2145. Epub 2008 Aug 21. Invest Ophthalmol Vis Sci. 2008. PMID: 18719078 Free PMC article.

7

Association between gene expression profile, proliferation and metastasis in uveal melanoma.

Onken MD, Worley LA, Harbour JW. Onken MD, et al. Curr Eye Res. 2010 Sep;35(9):857-63. doi: 10.3109/02713683.2010.493265. Curr Eye Res. 2010. PMID: 20795869 Free PMC article.

8

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.

Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW. Landreville S, et al. Among authors: onken md. Clin Cancer Res. 2012 Jan 15;18(2):408-16. doi: 10.1158/1078-0432.CCR-11-0946. Epub 2011 Oct 28. Clin Cancer Res. 2012. PMID: 22038994 Free PMC article.

9

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.

Matatall KA, Agapova OA, Onken MD, Worley LA, Bowcock AM, Harbour JW. Matatall KA, et al. Among authors: onken md. BMC Cancer. 2013 Aug 5;13:371. doi: 10.1186/1471-2407-13-371. BMC Cancer. 2013. PMID: 23915344 Free PMC article.

10

Uveal melanoma cells utilize a novel route for transendothelial migration.

Onken MD, Li J, Cooper JA. Onken MD, et al. PLoS One. 2014 Dec 15;9(12):e115472. doi: 10.1371/journal.pone.0115472. eCollection 2014. PLoS One. 2014. PMID: 25506912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters